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ABSTRACT 
During the first months of SARS-CoV-2 evolution in a new host, contrasting 
hypotheses have been proposed about the way the virus has evolved and diversified 
worldwide. The aim of this study was to perform a comprehensive evolutionary 
analysis to describe the human outbreak and the evolutionary rate of different 
genomic regions of SARS-CoV-2.  
The molecular evolution in nine genomic regions of SARS-CoV-2 was analyzed using 
three different approaches: phylogenetic signal assessment, emergence of amino 
acid substitutions, and Bayesian evolutionary rate estimation in eight successive 
fortnights since the virus emergence.  
All observed phylogenetic signals were very low and tree topologies were in 
agreement with those signals. However, after four months of evolution, it was 
possible to identify regions revealing an incipient viral lineage formation despite the 
low phylogenetic signal, since fortnight 3. Finally, the SARS-CoV-2 evolutionary rate 
for regions nsp3 and S, the ones presenting greater variability, was estimated as 
1.37 x 10-3 and 2.19 x 10-3 substitution/site/year, respectively.  
In conclusion, results from this work about the variable diversity of crucial viral 
regions and determination of the evolutionary rate are consequently decisive to 
understand essential features of viral emergence. In turn, findings may allow the first 
 
 














time characterization of the evolutionary rate of S protein, crucial for vaccine 
development. 
KEYWORDS: SARS-CoV-2, Phylogeny, Evolution, Evolutionary Rate 
Introduction 
Coronaviruses belong to Coronaviridae family and have a single strand of positive-
sense RNA genome of 26 to 32 kb in length [1]. They have been identified in different 
avian hosts as well as in various mammals including bats, mice, dogs, etc. [2,3]. 
Periodically, new mammalian coronaviruses are identified. In late December 2019, 
Chinese health authorities identified groups of patients with pneumonia of unknown 
cause in Wuhan, Hubei Province, China [4]. The pathogen, a new coronavirus called 
SARS-CoV-2 [5], was identified by local hospitals using a surveillance mechanism for 
"pneumonia of unknown etiology" [4,6,7]. The pandemic spread rapidly and more than 
28 million confirmed cases and nearly 900,000 deaths was reported in just over an 
eight months period [8]. The rapid viral spread raised interesting questions about the 
way its evolution is driven during the pandemic. From the SARS-CoV-2 genome, 16 
non-structural proteins (nsp1-16), 4 structural proteins [spike (S), envelope (E), 
membrane (M) and nucleoprotein (N)], and other proteins essential to complete the 
replication cycle have been translated [9,10]. The large amount of currently available 
information allows knowing, as never before, the real-time evolution history of a virus 
since its interspecies jump [11]. Most studies published to date have characterized the 
viral genome and evolution by analyzing complete genome sequences [12,13,14,15]. 
Despite this, until now, the viral genomic region providing the most accurate 
information to characterize SARS-CoV-2, could not be established. This lack of 
information prevents from investigating its molecular evolution and monitoring of 
biological features affecting the development of antiviral drugs and vaccines. 
Therefore, the aim of this study was to perform a comprehensive viral evolutionary 
 
 














analysis in order to describe the human outbreak and the molecular evolution rate of 
different genomic regions of SARS-CoV-2. 
Materials and Methods 
Datasets 
In order to generate a dataset representing different geographic regions and time 
evolution of the SARS-CoV-2 pandemic from December 2019 to April 2020, data of 
all the complete genome sequences available at GISAID (https: //www.gisaid.org /) 
on April 18, 2020 were collected. Data inclusion criteria were: a.- complete genomes, 
b.- high coverage level, and c.- human hosts only (no other animals, cell culture, or 
environmental samples). Complete genomes were aligned using MAFFT against the 
Wuhan-Hu-1 reference genome (NC_045512.2, EPI_ISL_402125). The resulting 
multiple sequence alignment (Dataset 1) was split in nine datasets corresponding to 
nine coding regions: a.- four structural proteins [envelope (E), nucleocapsid (N), 
spike (S), Orf3a], b.- four nonstructural proteins (nsp1, nsp3, Orf6, and nsp14), and 
c.- an unknown function protein (Orf8).  
More than six thousand SARS-CoV-2 publicly available nucleotide sequences were 
downloaded. After selection of data according to the inclusion criteria, 1616 SARS-
CoV-2 complete genomes were included in Dataset 1. Sequences of this Dataset 1 
came from 55 countries belonging to the five continents as follows: Africa: 39 
sequences, Americas: 383 sequences, Asia: 387 sequences, Europe: 686 
sequences, and Oceania: 121 sequences. After elimination of sequences with 
indeterminate or ambiguous positions, the number of analyzed sequences for each 
region was: nsp1, 1608; nsp3, 1511; nsp14, 1550; S, 1488; Orf3a, 1600; E, 1615; 
Orf6, 1616; Orf8, 1612; and N, 1610. Finally, nucleotide sequences were grouped by 
fortnight (FN) according to their collection date. Table 1 summarizes the number of 
sequences per fortnight since the beginning of the pandemic up to FN 8. On the 
 
 














other hand, Dataset 2 was created using only variable sequences of each region 
analyzed in Dataset 1. Thus, Dataset 1 was used for the analysis of amino acid 
substitutions and Dataset 2 was used for the phylogenetic signal analysis and the 
Bayesian coalescent trees construction. 
Phylogenetic signal 
To determine the phylogenetic signal of each of the nine generated alignments, 
Likelihood Mapping analyzes were carried out [16], using the Tree Puzzle v5.3 
program [17] and the Quartet puzzling algorithm. This algorithm allowed analyzing the 
tree topologies that can be completely solved from all possible quartets of the n 
alignment sequences using maximum likelihood. An alignment with defined tree 
values greater than 70-80% presents strong support from the statistical point of view 
[17]. Identical sequences were also removed with ElimDupes (available at 
https://www.hiv.lanl.gov/content/sequence/elimdupesv2/elimdupes.html) as they 
increase computation time and provide no additional information about dated 
phylogeny. The best-fit evolutionary model to each dataset was selected based on 
the Bayesian Information Criterion obtained with the JModelTest v2.1.10 software [18].  
Analysis of amino acid substitutions 
Entropy-One (available at 
https://www.hiv.lanl.gov/content/sequence/ENTROPY/entropy_one.html) was used in 
determining the frequency of amino acids at each position for the nine genomic 
regions analyzed and evaluating their permanence in the eight investigated fortnights 
in Dataset 1. 
Bayesian coalescence and phylogenetic analysis 
To study the relationship among SARS-CoV-2 sequences, nine regions of the viral 
genome were investigated by Bayesian analyses. Phylogenetic trees were 
constructed using Bayesian inference with MrBayes v3.2.7a [19]. Each gene was 
 
 














analyzed independently with the same dataset used for the phylogenetic signal 
analysis so that non-identical sequences were included in the analysis. Analyses 
were run for five million generations and sampled every 5000 generations. 
Convergence of parameters [effective sample size (ESS) ≥ 200, with a 10% burn-in] 
was verified with Tracer v1.7.1 [20]. Phylogenetic trees were visualized with FigTree 
v1.4.4. 
Evolutionary rate 
The estimation of the nucleotide evolutionary rate was made with the Beast v1.10.4 
program package [21]. Analyses were run at the CIPRES Science Gateway server [22]. 
Three hundred and twelve sequences without indeterminations corresponding to the 
nsp3 (5835nt) and S (3822nt) genes were randomly selected from Dataset 1. The 
sequences represent all the fortnights and most of the geographical locations 
sampled until April 17. Temporal calibration was performed by date of sampling. The 
appropriate evolutionary model was selected as described above for phylogenetic 
signal analysis. Nucleotide substitution TIM model was used for nsp3, and HKY 
model for S. Analysis were carried out under a relaxed (uncorrelated lognormal) 
molecular clock model as suggested by Duchene & col. [23] and with an exponential 
demographic, proper for early viral samples from an outbreak [24]. Independent runs 
were performed for each dataset and a Markov chain Monte Carlo (MCMC) with a 
length of 1.3x109 steps, sampling every 1.3x106 steps, was setup. The convergence 
of the "mean rate" parameter [effective sample size (ESS) ≥ 200, burn-in 10%] was 
verified with Tracer v1.7.1 [20]. Additionally, in order to verify the obtained results, 15 
independent replicates of the analysis were performed with the time calibration 
information (date of sampling) randomized as described by Rieux & Khatchikian, 




















Using bioinformatics tools, a phylogenetic signal study was carried out in order to 
identify the most informative SARS-CoV-2 genomic regions. The likelihood mapping 
analysis showed that most genes has very poor phylogenetic signal with high values 
in the central region that represents the area of unresolved quartets (Figure 1). 
Accordingly, genes could be separated into three groups. A group with little or no 
phylogenetic signal (E, Orf6, Orf8, nsp1, and nsp14), a second group with low 
phylogenetic signal (Orf3a and N), and a last group with relatively more phylogenetic 
signal (S and nsp3) but still low to be considered a robust one (unresolved quartets 
>40%).  
Analysis of amino acid substitutions 
The analysis of amino acid substitutions by fortnights was useful to study the viral 
evolutionary dynamics in the context of the beginning of the pandemic. When 
analyzing amino acid sequences from different time periods, changes were observed 
in 5 out of 9 genomic regions and only in 14 out of the 4975 (0.28%) evaluated 
residues. In most of the regions, except nsp1, nsp14, E, and Orf6, 2 to 6 amino acids 
emerge since FN3 and remain unchanged until the end of the follow-up period (Table 
2). Particularly, in Orf8 region, early selection of two amino acid substitutions (V62L 
and L84S) was observed on FN2. On the other hand, in the S region, the D614G 
substitution started with less than 2% in FN3 and FN4 and reached 88% in the last 
fortnight. In a similar way, the Q57H (Orf3a) substitution increased from 6% to 34% 
while L84S (Orf8) start to be selected in FN2 and reached 6% at FN8. The R203K 
and G204R substitutions from the N region emerged in FN4 and increased their 
population proportion to values greater than 20% towards the end of the follow-up 
period. Moreover, the emergence of a great number of sporadic substitutions that 
 
 














remains in the population for a short period (1-3 fortnights) was observed in the nine 
analyzed regions. Indeed, 333 (6.83%) positions from the total analyzed presented at 
least one substitution throughout the eight fortnights. Table 3 summarizes the 
number of variable positions, number of mutations, and number of sequences with 
mutations by region.  
Bayesian coalescence analysis 
In this study, trees were performed by Bayesian analysis instead of by distance, 
likelihood, or parsimony methods. Consistently with the phylogenetic signal analysis, 
trees for nsp1, E, and Orf6 showed a star-like topology. Nevertheless, different 
proportions of clade formation could be observed in trees of Orf8, nsp14, Orf3a, N, S, 
and nsp3 regions (Figure 2). Finally, from the mentioned regions, nsp3 and S 
showed a better clade constitution. This analysis allowed to differentiate regions 
displaying a diversification process (nsp3, nsp14, Orf3a, S, Orf8, and N) from those 
that even after four months showed an incipient one (nsp1, E, and Orf6). 
Furthermore, this nucleotide analysis is complemented by the previous study of 
amino acid variations in each region. However, it is important to note that due to the 
low phylogenetic signal observed for each region, results can only be considered as 
preliminary. 
Evolutionary rate 
Nsp3 and S sequences were selected to perform the evolutionary rate analysis since 
both regions provided the best phylogenetic information among studied regions. The 
observed evolutionary rate for SARS-CoV-2 nsp3 protein was estimated as 1.37 x10-
3 nucleotide substitutions per site per year (s/s/y) (95% HPD interval 9.16 x10-4 to 
1.91 x10-3). On the other hand, the corresponding figures for S were estimated in 
2.19 x10-3 nucleotide s/s/y (95% HPD interval 3.19 x10-3 to 1.29 x10-3). In both 
genomic regions, date-randomization analyses showed no overlapping between the 
 
 














95% HPD substitution-rate intervals obtained from real data and date-randomized 
datasets. This fact suggests that the original dataset has enough temporal signal to 
perform analyses with temporal calibration based on tip-dates (Figure 3). 
Discussion 
The phylogenetic characterization of an emerging virus is crucial to understand the 
way the virus and the pandemic will evolve. Thereby, a detailed study of the SARS 
CoV-2 genome allows, on the one hand, to contribute to the knowledge of viral 
diversity in order to detect the most suitable regions to be used as antivirals or 
vaccines targets. On the other hand, the large amount of information that has been 
continuously generated since SARS CoV-2 emergence in human beings is allowing 
studying its genome and describing the real-time evolution of a new virus like never 
before.  
In the present study, the molecular evolution and viral lineages of SARS-CoV-2 in 
nine genomic regions, during eight successive fortnights, were analyzed using three 
different approaches: phylogenetic signal assessment, the emergence of amino acid 
substitutions, and Bayesian evolutionary rate estimation. In this context, the observed 
phylogenetic signals of nine coding regions were very low and the obtained trees 
were consistent with this finding, showing star-like topologies in some viral regions 
(nsp1, E, and Orf6). However, after a four months evolution period, it was possible to 
identify regions (nsp3, S, Orf3a, Orf8, and N) revealing an incipient formation of viral 
lineages, despite the phylogenetic signal, both at the nucleotide and amino acid 
levels from FN3. Based on these findings, the SARS-CoV-2 evolutionary rate was 
estimated, for the first time, for the two regions showing higher variability (S and 
nsp3). 
In respect for the phylogenetic signal, several simulation studies has proven that for a 
set of sequences to be considered robust, the central and lateral areas representing 
 
 














the unresolved quartets, must not be greater than 40% [16]. In this regard, none of the 
nine analyzed regions has met this requirement. Three regions (E, nsp1, and Orf6) 
presented values of 100% unresolved quartets. Most regions (nsp14, Orf3a, Orf8, 
and N) reached values higher than 85%. Only in regions nsp3 and S, the number of 
unresolved quartets dropped to ~ 60%. Thus, despite being a virus with an RNA 
genome, the short time elapsed since its emergence, and possibly genetic 
restrictions, have led to a constrained evolution of SARS-CoV-2 in these months. For 
this reason, it is expected that trees generated from SARS-CoV-2 partial sequences 
in the first months of the pandemic are unreliable for defining clades. Therefore, they 
should be analyzed with caution. 
Since Bayesian analysis allows to infer phylogenetic patterns from tree distributions, 
it represents a more reliable tool to compare different evolutionary behaviors. 
Bayesian analysis helps to obtain a tree topology that is closer to reality in the current 
conditions of SARS-CoV-2 pandemic [26]. The phylogenetic analysis for nsp1, E, and 
Orf6 regions confirmed the star-like topologies in accordance to a lower 
diversification of these regions using the sequences available up to FN8 (Figure 2). 
Trees generated from nsp14 and Orf8 are at an intermediate point, where the 
formation of small clusters can be observed. In fact, a mutation at position 28,144 
(Orf8: L84S) has been proposed as a possible marker for viral classification [27,28]. 
Finally, trees obtained from regions Orf3a, N, nsp3, and S showed the best clade 
formation. Indeed, in the most variable regions nsp3 and S, it can be clearly seen 
that sequences are separated into two large groups. Despite the aforementioned for 
the nsp3 and S regions, even clusters with very high support values should be taken 
with precaution and longer periods should be considered to obtain more accurate 
phylogenetic data. However, even when data are not the most accurate to study the 
 
 














spread or clade formation [29, 30], they provide a good representation of the way the 
virus is evolving.  
The analysis of amino acid frequencies allowed identifying different degree of region 
conservation throughout the viral genome because of positive and negative 
pressures. In particular, nsp3, S, Orf8, and N showed some substitutions in high 
frequencies. This would indicate, as other authors have previously reported, the 
frequent circulation of polymorphisms due to significant positive pressure [13,27,31]. 
Additionally, since S and N are among the candidates to be used in the formulation of 
vaccines and antibody treatment, it will be important to monitor these substitutions in 
different geographic regions in order to improve treatment and vaccination efficacy 
[32,33,34]. In particular, the appearance of the D614G variant in the third week and its 
rapid increase until reaching an 88% prevalence in the eighth week could reflect an 
improvement in viral fitness, as it has been previously reported [35]. This is supported 
by studies in SARS CoV showing that predicted S protein domains underwent the 
most extensive amino acid substitutions and the strongest positive selection [36]. 
Contrarily, in regions nsp1, nsp14, E, and Orf6 no substitutions were selected during 
the first 4 months of the pandemic. This would suggest that these regions present 
constraints to change due to a great negative selection pressure, as it has been 
recently reported [13].  
In the present study, the evolutionary rate for SARS-CoV-2 genes was estimated by 
analyzing a large number of sequences, which were carefully curated and had a 
good temporal and spatial structure. Additionally, the most phylogenetically 
informative regions of the genome (nsp3 and S) were used for analysis, reinforcing 
the results confidence. Previous studies on SARS-CoV-2 have reported similar data 
ranging from 1.79 x 10−3 to 6.58 x 10−3 s/s/y for the complete genome [6,37]. However, 
in both articles, small datasets of complete genomes were used (N=32 and 54, 
 
 














respectively). As studies were performed early in the outbreak and due to datasets 
temporal structure, analysis could have led to less precise estimates of the 
evolutionary rate [23]. Alternatively, another study from van Dorp et al. (2020), 
analyzing 7,666 sequences, has obtained different results with a remarkably low 
evolutionary rate (6 x 10-4 nucleotide/genome/year) [15]. However, it is important to 
consider that van Dorp et al. (2020) estimate the evolutionary rate using the complete 
genome, including several highly conserved genomic regions, while in our work, the 
estimation was performed with the most variable regions of the genome. Additionally, 
tests randomizing the dates of nsp3 and S datasets were carried out; they showed 
that these partial genomic regions have enough temporal structure and that they are 
informative, allowing the estimation of evolutionary rates. In this context, our results 
(1.37 x 10-3 s/s/y for NSp3 and 2.19 x 10-3 s/s/y for S) are in close agreement with 
those published for SARS-CoV genome, which have been estimated to range 
between 0.80 to 3.01 x 10-3 s/s/y [36,38,39]. In particular, Zhao et al. (2004) estimated a 
similar evolutionary rate for SARS-CoV S gene [39]. Moreover, our estimated values 
are in the same order magnitude as other RNA viruses [40]. Even though we should 
be cautious with these results interpretation, our date-randomization analysis 
indicated a robust temporal signal. 
In addition, the importance of separately studying the evolutionary rate of the S 
genomic region arises from the fact that it represents the main target for antiviral 
agents and vaccines since it includes the SARS-CoV-2 binding receptor domain 
(RBD), a crucial structure for the virus to enter host cells, and binding site for 
neutralizing antibodies [41]. "Furthermore, a re-infection case occurring 142 days after 
the first infection episode has been reported. The second infection virus sequence 
showed 4 changes out of 14 amino acid in the spike protein and two changes in nsp3 
[42], the two genome genes considered phylogenetically most informative in our work. 
 
 














Since neutralizing antibodies are targeted against the spike protein [43], a high 
evolutionary rate in this gene can imply changes in the circulating virus and therefore 
turning it less susceptible to neutralizing antibodies generated during a first infection. 
In fact, certain mutations in the spike protein, more precisely in the receptor binding 
and in the N-terminal domain, have been reported to confer a reduced susceptibility 
to neutralizing antibodies [44,45]. For this reason, the evolutionary rate of S and nsp3 
genes, reported separately here for the first time, is a crucial issue as it may have 
implications for vaccines development, vaccine efficacy, or natural re-infections." 
Despite limitations of the evolutionary study of an emerging virus, where the selection 
pressures are still low and therefore its variability low, this work has a strength: the 
extremely careful selection of a big sequence dataset to be analyzed. First, 
sequences were selected considering their good temporal signal and their balanced 
spatial (geographic) distribution. Secondly, attention was paid to eliminate sequences 
with low coverage and indeterminacies that could generate bias in the phylogenetic 
analysis of a virus that is beginning to evolve in a new host. 
The appearance of a virus means an adaptation challenge. In this sense, both 
SARS-CoV and SARS-CoV-2 have shown a rapid emergence of several lineages in 
a short period [36,46], reflecting a high adaptability. However, the spike of SARS-CoV-2 
binds to the host cell receptor with a 10 to 20-fold greater affinity compared to SARS-
CoV and contains a polybasic (furin) cleavage site insertion, which may enhance the 
virus infectivity [47]. Thereby, changes in the S protein constitute an important 
contribution, turning SARS-CoV 2 to spill over stage and show a significantly higher 
spread than SARS-CoV and MERS-CoV. Due to this fact, SARS-CoV 2 becomes the 
most important pandemic of the century. In this context, results obtained in this work 
about the uneven diversity of nine crucial viral regions and the determination of the 
evolutionary rate, are decisive to understanding essential features of viral 
 
 














emergence. Nevertheless, monitoring SARS-CoV-2 population will be required to 
determine the evolutionary dynamics of new mutations as well as to understand the 
way they affect viral fitness in human hosts. 
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Table 1. Number of SARS-CoV-2 sequences by fortnight (Temporal structure) 
Fortnight Date Median of analyzed sequences 
(Q1-Q3) 
FN1 12/24/2019 to 
12/31/2019 
15 
FN2 01/01/2020 to 
01/15/2020 
19 
FN3 01/16/2020 to 
01/31/2020 
145 (136-145.5) 
FN4 02/01/2020 to 
02/15/2020 
119 (113-120) 
FN5 02/16/2020 to 
03/02/2020 
258 (247-259) 
FN6 03/03/2020 to 
03/17/2020 
403 (390-406) 
FN7 03/18/2020 to 
04/01/2020 
447 (416-450) 
FN8 04/02/2020 to 
04/17/2020 
199 (197-201) 
TOTAL  1488 to 1616 
FN: Fortnight; Q1=quartile 1, Q3=quartile 3. The total number of sequences is variable 
depending on the analyzed region (nsp1, 1608; nsp3, 1511; nsp14, 1550; S, 1488; Orf3a, 


















Table 2. Amino acids selected by region and fortnight. The number indicates the 




Amino acid percentage by FN 























































































































Only regions where amino acid change was selected and remained until the last analyzed 
fortnight are shown. FN: Fortnight; aa: amino acid 
Table 3. Number of variable positions, number of mutations, and number of 
sequences with mutation by region  
Region 
Nº of variable aa 
positions (%) 
Nº of aa 
substitutions 
Nº of sequences with 
aa substitutions (%) 
nsp1 (180aa) 3 (1.7) 37 37 (2.4) 
 
 














nsp3 (1945aa) 158 (8.1) 322 294 (19.3) 
nsp14 (527aa) 6 (1.4) 83 83 (5.5) 
S (1273aa) 76 (5.9) 1013 904 (59.4) 
Orf3a (275aa) 11 (4) 491 468 (30.7) 
E (75aa) 5 (6.7) 6 6 (0.4) 
Orf6 (60aa) 7 (11.6) 9 9 (0.6) 
Orf8 (121aa) 14 (11.6) 312 288 (18.9) 
N (419aa) 53 (12.6) 760 470 (30.9) 
Total (4875aa) 333 (6.8) 3033 - 



















Figure 1 Phylogenetic signal for SARS-CoV-2 datasets. Presence of phylogenetic 
signal was evaluated by likelihood mapping, unresolved quartets (center) and partly 
resolved quartets (edges) for genomes available on April 17 for the nine analyzed 
regions: nsp1 (29 sequences), nsp3 (225 sequences), nsp14 (65 sequences), S (183 
sequences), Orf3a (74 sequences), E (11 sequences), Orf6 (12 sequences), Orf8 (23 
sequences), and N (113 sequences). Presence of strong phylogenetic signal (<40% 


















Figure 2 Bayesian trees of 29 sequences of nsp1 (540nt), 225 sequences of nsp3 
(5835nt), 65 sequences of nsp14 (1581nt), 183 sequences of S (3822nt), 74 
sequences of Orf3a (828nt), 11 sequences of E (228nt), 12 sequences of Orf6 
(186nt), 23 sequences of Orf8 (366nt), and113 sequences of N (1260nt). Scale bar 



















Figure 3 Comparison of the evolutionary rates estimated using BEAST for the 
original dataset and the date-randomized datasets (312 sequences). This analysis 
was performed for regions nsp3 (5835nt) and S (3822nt). s.s.y = 
substitutions/site/year.  
 
